Aemetis’ (AMTX) “Buy” Rating Reaffirmed at HC Wainwright

HC Wainwright restated their buy rating on shares of Aemetis (NASDAQ:AMTX) in a research note issued to investors on Monday morning,Benzinga reports. HC Wainwright currently has a $28.00 price objective on the specialty chemicals company’s stock.

Separately, Ascendiant Capital Markets cut their target price on shares of Aemetis from $20.00 to $19.00 and set a “buy” rating for the company in a research report on Tuesday, September 3rd. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $12.95.

Aemetis Price Performance

Aemetis stock opened at $2.59 on Monday. Aemetis has a one year low of $2.10 and a one year high of $7.03. The business’s fifty day moving average is $3.30 and its 200 day moving average is $3.00. The stock has a market capitalization of $128.81 million, a PE ratio of -1.15 and a beta of 1.35.

Aemetis (NASDAQ:AMTX) last posted its earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.47) by $0.09. The company had revenue of $81.44 million for the quarter, compared to the consensus estimate of $77.79 million. During the same quarter in the prior year, the company posted ($0.59) EPS. As a group, sell-side analysts expect that Aemetis will post -2.02 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Bank of New York Mellon Corp purchased a new stake in Aemetis in the second quarter worth about $306,000. Rhumbline Advisers increased its holdings in Aemetis by 2,837.1% in the 2nd quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after acquiring an additional 50,528 shares in the last quarter. Hutchinson Capital Management CA bought a new stake in Aemetis during the 2nd quarter worth approximately $70,000. Susquehanna Fundamental Investments LLC lifted its holdings in Aemetis by 287.4% during the second quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock valued at $379,000 after purchasing an additional 93,536 shares in the last quarter. Finally, FMR LLC boosted its position in shares of Aemetis by 68.2% in the third quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock worth $52,000 after purchasing an additional 9,137 shares during the period. Hedge funds and other institutional investors own 27.02% of the company’s stock.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.